Company Filing History:
Years Active: 2020
Title: Diego Celdran-Bonafonte: Innovator in Vascular Implant Technology
Introduction
Diego Celdran-Bonafonte is a notable inventor based in Cincinnati, OH (US). He has made significant contributions to the field of vascular implant technology, particularly with his innovative designs aimed at improving blood flow in medical applications.
Latest Patents
Celdran-Bonafonte holds a patent for an "Arteriovenous fistula implant effective for inducing laminar blood flow." This vascular implant device is specifically designed to decrease turbulence in blood flow through an arteriovenous fistula. The implant features an arterial section with a straight hollow tube and a venous section that includes a curved hollow tube. This curved section is divided into an orthogonal portion at the juncture of the arterial section, a curved portion that bends approximately 90 degrees, and a straight extension portion that runs parallel to the arterial section. The design incorporates a plurality of flow-conditioning tabs along the lumen surface, which are strategically arranged to convert turbulent blood flow into substantially laminar flow. This innovation minimizes oscillatory shear stress on the venous endothelium as blood exits the device and enters the vein.
Career Highlights
Diego Celdran-Bonafonte is affiliated with the University of Cincinnati, where he continues to advance his research and development in vascular technologies. His work has garnered attention for its potential to improve patient outcomes in vascular surgeries.
Collaborations
Celdran-Bonafonte has collaborated with notable colleagues, including Keith Louis Saum and Prabir Roy-Chaudhury. Their combined expertise contributes to the innovative advancements in the field of vascular implants.
Conclusion
Diego Celdran-Bonafonte is a pioneering inventor whose work in vascular implant technology is making a significant impact in the medical field. His patented designs are set to enhance the effectiveness of arteriovenous fistulas, ultimately benefiting patient care.